Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

A. G. Villasante-Tezanos; C. Rohde; J. Nielsen; J. de Leon

doi:10.1111/acps.13184

Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

A. G. Villasante-Tezanos
, C. Rohde
, J. Nielsen
, J. de Leon

Producción científica: Letter › revisión exhaustiva

31 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	66-67
Número de páginas	2
Publicación	Acta Psychiatrica Scandinavica
Volumen	142
N.º	1
DOI	https://doi.org/10.1111/acps.13184
Estado	Published - jul 1 2020

Nota bibliográfica

Funding Information:
These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.

Financiación

These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.

Financiadores
Lorraine Maw

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Psychiatry and Mental health

Acceder al documento

10.1111/acps.13184

Otros archivos y enlaces

Citar esto

@article{c72d9bedc8ad4d40a619f63ec68c4d27,

title = "Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia",

keywords = "clozapine/adverse effects, clozapine/toxicity, infection, pneumonia, respiratory aspiration",

author = "Villasante-Tezanos, \{A. G.\} and C. Rohde and J. Nielsen and \{de Leon\}, J.",

note = "Funding Information: These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.",

year = "2020",

month = jul,

day = "1",

doi = "10.1111/acps.13184",

language = "English",

volume = "142",

pages = "66--67",

number = "1",

}

TY - JOUR

T1 - Pneumonia risk

T2 - approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

AU - Villasante-Tezanos, A. G.

AU - Rohde, C.

AU - Nielsen, J.

AU - de Leon, J.

N1 - Funding Information: These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.

PY - 2020/7/1

Y1 - 2020/7/1

KW - clozapine/adverse effects

KW - clozapine/toxicity

KW - infection

KW - pneumonia

KW - respiratory aspiration

UR - https://www.scopus.com/pages/publications/85088152705

UR - https://www.scopus.com/pages/publications/85088152705#tab=citedBy

U2 - 10.1111/acps.13184

DO - 10.1111/acps.13184

M3 - Letter

C2 - 32415875

AN - SCOPUS:85088152705

SN - 0001-690X

VL - 142

SP - 66

EP - 67

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

IS - 1

ER -

Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

Nota bibliográfica

Financiación

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto